Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Atypical facial pain in multiple sclerosis caused by spinal cord seizures: a case report and review of the literature.
Developmental Origin of Oligodendrocyte Lineage Cells Determines Response to Demyelination and Susceptibility to Age-Associated Functional Decline.
Interferon beta treatment of multiple sclerosis increases serum interleukin-7.
CLIPPERS complicating multiple sclerosis causing concerns of CNS lymphoma.
Treatment Burden and Chronic Illness: Who is at Most Risk?
Beta-Interferon, Glatiramer Acetate Cost-Effective in MS
Selective Chemical Modulation of Gene Transcription Favors Oligodendrocyte Lineage Progression.
Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis.
Burden of neurological conditions in Canada.
Radiologically isolated syndrome: 5-year risk for an initial clinical event.
Zebrafish as a model to investigate CNS myelination.
VLA-4/CD49d downregulated on primed T lymphocytes during interferon-beta therapy in multiple sclerosis.
The effects of prolonged wear of textured shoe insoles on gait, foot sensation and proprioception in people with multiple sclerosis: study protocol for a randomised controlled trial.
Vitamin D3 attenuates oxidative stress and cognitive deficits in a model of toxic demyelination.
Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome.
Long-term effectiveness of glatiramer acetate in clinical practice conditions.
Tract-specific and age-related variations of the spinal cord microstructure: a multi-parametric MRI study using diffusion tensor imaging (DTI) and inhomogeneous magnetization transfer (ihMT).
Subclinical primary retinal pathology in neuromyelitis optica spectrum disorder.
Boxed warning of HBV risk added to Rituxan, Arezerra
Teriflunomide
Persistency of neutralizing antibodies depends on titer and interferon-beta preparation.
Low-contrast acuity measures visual improvement in phase 3 trial of natalizumab in relapsing MS.
Dimethyl fumarate induces necroptosis in colon cancer cells through glutathione depletion/ROS increase/MAPKs activation pathway.
Episode 6 with Dr. Jeffrey Dunn on biomarkers and personalized medicine
Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.

Pages